Riskpilot← Back to searchSign inGet full accessSkandinavisk Doseringsteknik AB
ABActiveOrg 5567248652Hamngatan 2Manufacture of machinery for food, beverage and tobacco processing · NACE 2893Est. 20072 employees
Revenue 2025
SEK 2M
-38% vs 2024
EBITDA margin
4.4%
-62% vs 2024
Equity ratio
58.3%
Financial strength
Net profit 2025
SEK 57K
-56% vs 2024
| Revenue | SEK 2M | -38% |
| EBITDA | SEK 88K | -62% |
| Net profit | SEK 57K | -56% |
| Total assets | SEK 922K | -21% |
| Equity | SEK 538K | +12% |
| Employees | 2 | — |
Legal name
Skandinavisk Doseringsteknik AB
Org number
5567248652
Legal form
Aktiebolag
NACE code
2893 · Manufacture of machinery for food, beverage and tobacco processing
Founded
1 mars 2007
Share capital
SEK 100 200
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva service samt tillverkning och reparationer av maskiner inom främst livsmedelsindustrin.
Address
Hamngatan 2
Phone
+46707507471
Email
henrikuthbulk@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 505 | 6 735 | 2 240 | 3 232 | 2 005 |
| Staff expenses | — | −1 923 | −1 019 | −1 114 | −961 |
| EBITDA | −590 | −310 | 713 | 231 | 88 |
| Depreciation & amort. | −276 | −249 | −191 | −99 | −32 |
| EBIT | −866 | −559 | 522 | 132 | 56 |
| Net financials | −30 | −39 | −19 | −3 | 1 |
| Profit before tax | −895 | −473 | 213 | 129 | 57 |
| Tax | −0 | — | — | — | — |
| Net profit | −895 | −473 | 213 | 129 | 57 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 191 | 1 386 | 994 | 1 173 | 922 |
| Equity | 562 | 139 | 352 | 481 | 538 |
| Long-term debt | 870 | 638 | 396 | 362 | 134 |
| Short-term debt | 759 | 609 | 246 | 330 | 251 |
| Total debt | 1 629 | 1 246 | 642 | 692 | 384 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20212025
Equity ratio
58.3%
This company
38.2%
Market median
+53% vs market
20212025
Return on equity
10.5%
This company
18.4%
Market median
+43% vs market
20212025
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20212025
Asset turnover
2.17×
This company
1.12×
Market median
+94% vs market
20212025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HU Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (2) | ||
BH | Audit | 2021 – 2022 |
SK | Audit | 2022 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Skandinavisk Doseringsteknik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt-Ola Håkan Månsson | Audit | 0 companies |
| Sara Karin Sjöberg Einarsson | Audit | 0 companies |
| Henrik Uth | Chief Executive Officer | 0 companies |
| Karl-Gustav Fredrik Karlsson | Deputy Board Member | 0 companies |